Background: Mechanical thrombectomy is recommended for patients with middle cerebral artery (MCA) segment 1 (M1) occlusion within 6 hours of symptom onset by American Stroke Association. This study aimed to demonstrate the safety of endovascular treatments in MCA M1 infarcts and compare the safety and effectiveness of direct thrombectomy and intravenous tissue plasminogen activator (iv-tPA) bridging therapy before mechanical thrombectomy. Methods: A retrospective, observational study was conducted on patients with large MCA infarction on brain imaging. Patients who received endovascular treatment were included in the endovascular therapy (EVT) group, while who received only iv-tPA were included in the iv-tPA group. Patients who underwent direct mechanical thrombectomy or bridging therapy were identified. Clinical outcomes at 3 months and symptomatic intracerebral hemorrhage (SIH) rates were compared between the groups. Results: The EVT group showed good clinical outcomes (modified Rankin score [mRS] ≤ 2) at 3 months was significantly higher than the iv-tPA group, while; SIH rates were similar. There was no statistically significant difference in terms of good clinical outcomes between direct mechanical thrombectomy and bridging therapy groups. But, SIH rates were significantly higher in the direct mechanical thrombectomy group. Conclusion: Our study showed that for large MCA infarct, EVT provides better clinical outcomes than iv-tPA alone, and that direct mechanical thrombectomy may be an effective choice for patients who are unsuitable for iv-tPA. Additionally, our findings also contribute to the literature indicating that bridging therapy is a safe option.